3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Sarcoma, Synovial
1
Prolactin-Producing Pituitary Tumor
1
Lymphoma, Follicular
1
Gastro-enteropancreatic neuroendocrine tumor
1
Desmoplastic Small Round Cell Tumor
1
Interventions
Cyclophosphamide
5
fludarabine
3
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Doxorubicin
2
peposertib
1
pembrolizumab
1
pasireotide
1
olaparib
1
lutetium Lu 177 dotatate
1
liposomal doxorubicin
1
fludarabine phosphate
1
anlotinib
1
aldesleukin
1
Zoledronic Acid
1
X-Rays
1
Tablets
1
Rosuvastatin Calcium
1
Quality of Life
1
Phantoms, Imaging
1
Midazolam
1
Leukapheresis
1
Interleukin-2
1
Injections
1
Immunotherapy, Adoptive
1
Immune Checkpoint Inhibitors
1
Ifosfamide
1
Digoxin
1
Dacarbazine
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Sarcoma, Synovial
×
pasireotide
×
Clear all
NCT06456359
2025-01-13
PAMSARC
University Hospital Heidelberg
Phase 2
Recruiting
28 enrolled